Literature DB >> 24107261

HIV prevalence in China: integration of surveillance data and a systematic review.

Lei Zhang1, Eric P F Chow, Jun Jing, Xun Zhuang, Xiaoshan Li, Meiqi He, Huamin Sun, Xiaoyan Li, Marelize Gorgens, David Wilson, Lan Wang, Wei Guo, Dongming Li, Yan Cui, Lu Wang, Ning Wang, Zunyou Wu, David P Wilson.   

Abstract

BACKGROUND: Asian HIV epidemics are concentrated among particular behavioural groups, but large variations exist in epidemic types, timing, and geographical spread between countries and within countries, especially in China. We aimed to understand the complexity of HIV epidemics in China by systematically analysing prevalence trends by data source, region, population group, and time period.
METHODS: We collected HIV prevalence data from official national sentinel surveillance sites at the provincial level from Jan 1, 1995, to Dec 31, 2010. We also searched PubMed, VIP Chinese Journal Database (VIP), China National Knowledge Infrastructure, and Wanfang Data from Jan 1, 1990, to Dec 31, 2012, for independent studies of HIV prevalence. We integrated both sets of data, and used an intraclass correlation coefficient test to assess the similarity of geographical pattern of HIV disease burden across 31 Chinese provinces in 2010. We investigated prevalence trends (and 95% CIs) to infer corresponding incidence by region, population group, and year.
FINDINGS: Of 6850 articles identified by the search strategy, 821 studies (384,583 drug users, 52,356 injecting drug users, 186,288 female sex workers, and 87,834 men who have sex with men) met the inclusion criteria. Official surveillance data and findings from independent studies showed a very similar geographical distribution and magnitude of HIV epidemics across China. We noted that HIV epidemics among injecting drug users are decreasing in all regions outside southwest China and have stabilised at a high level in northwest China. Compared with injecting drug users, HIV prevalence in female sex workers is much lower and has stabilised at low levels in all regions except in the southwest. In 2010, national HIV prevalence was 9·08% (95% CI 8·04-10·52) in injecting drug users and 0·36% (0·12-0·71) in female sex workers, whereas incidence in both populations stabilised at rates of 0·57 (0·43-0·72) and 0·02 (0·01-0·04) per 100 person-years, respectively. By comparison, HIV prevalence in men who have sex with men increased from 1·77% (1·26-2·57) in 2000, to 5·98% (4·43-8·18) in 2010, with a national incidence of 0·98 (0·70-1·25) per 100 person-years in 2010. We recorded strong associations between HIV prevalence among at-risk populations in each province, supporting the existence of overlap in risk behaviours and mixing among these populations.
INTERPRETATION: HIV epidemics in China remain concentrated in injecting drug users, female sex workers, and men who have sex with men. HIV prevalence is especially high in southwest China. Sex between men has clearly become the main route of HIV transmission.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24107261     DOI: 10.1016/S1473-3099(13)70245-7

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  116 in total

1.  Generalisability of an online randomised controlled trial: an empirical analysis.

Authors:  Cheng Wang; Katie R Mollan; Michael G Hudgens; Joseph D Tucker; Heping Zheng; Weiming Tang; Li Ling
Journal:  J Epidemiol Community Health       Date:  2017-11-28       Impact factor: 3.710

2.  A retrospective analysis of the application of the Elecsys® HIV combi PT assay in southern China.

Authors:  Shaocong Liang; Guihua Deng; Shaosong Zhou; Jing Zeng; Weiqing Tan; Xiaopeng Yuan
Journal:  J Clin Lab Anal       Date:  2017-06-26       Impact factor: 2.352

3.  Stigma, Subsistence, Intimacy, Face, Filial Piety, and Mental Health Problems Among Newly HIV-Diagnosed Men Who Have Sex With Men in China.

Authors:  Haochu Howard Li; Eleanor Holroyd; Joseph Lau; Xiaoming Li
Journal:  J Assoc Nurses AIDS Care       Date:  2015-02-25       Impact factor: 1.354

4.  Predictors of Recent HIV Testing Among Chinese Men Who Have Sex with Men: A Barrier Perspective.

Authors:  Wenjian Xu; Yong Zheng; Michelle R Kaufman
Journal:  AIDS Patient Care STDS       Date:  2018-09-20       Impact factor: 5.078

5.  Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.

Authors:  Yanping Bao; Sarah Larney; Amy Peacock; Samantha Colledge; Jason Grebely; Matthew Hickman; Louisa Degenhardt; Janni Leung
Journal:  Int J Drug Policy       Date:  2019-05-21

6.  Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China.

Authors:  Shouli Wu; Min Gao; Jian Zheng; Pingping Yan; Wei Wang; Xiaoli Lu; Yuefeng Qiu; Yansheng Yan
Journal:  Virol Sin       Date:  2019-06-12       Impact factor: 4.327

7.  Sexual behaviors and HIV/syphilis testing among transgender individuals in China: implications for expanding HIV testing services.

Authors:  John Best; Weiming Tang; Ye Zhang; Larry Han; Fengying Liu; Shujie Huang; Bin Yang; Chongyi Wei; Joseph D Tucker
Journal:  Sex Transm Dis       Date:  2015-05       Impact factor: 2.830

8.  The HIV/AIDS epidemic among young people in China between 2005 and 2012: results of a spatial temporal analysis.

Authors:  X Zhang; W Tang; Y Li; T Mahapatra; Y Feng; M Li; F Chen; P Li; J Xing; S Qian; L Ge; K Bu; S Mahapatra; S Tang; L Wang; N Wang
Journal:  HIV Med       Date:  2016-08-24       Impact factor: 3.180

9.  Post-traumatic Stress Disorder Symptoms Among People Living with HIV/AIDS in Rural China.

Authors:  Sitong Luo; Chunqing Lin; Guoping Ji; Li Li
Journal:  AIDS Behav       Date:  2017-11

10.  Comparing Samples of Men Who Have Sex with Men Recruited Online and in Venues, Jiangsu Province, China, 2013.

Authors:  Ling-En Shi; Chongyi Wei; Willi McFarland; Hongjing Yan; Jianjun Li; H Fisher Raymond
Journal:  LGBT Health       Date:  2015-07-29       Impact factor: 4.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.